Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin Plus CTd in Newly Diagnosed Multiple Myeloma
NCT02248428Phase 3Unknown
- Sponsor
- Jinling Hospital
- Start
- Apr 2012
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clarithromycin in multiple myeloma (MM), sponsored by Jinling Hospital. Status: unknown.
02
Drugs
clarithromycin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02248428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02248428.